Xealth, a Seattle, WA-based digital prescribing platform, raised $11m in Series A financing.
Backers included new investors McKesson Ventures, Novartis, Philips and ResMed and existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin Health Network.
The company intends to use the funds to accelerate expansion of its platform.
Originally incubated and spun out of Providence St. Joseph Health in 2017, and led by CEO Mike McSherry, Xealth is a digital health prescribing platform that enables clinicians to integrate, prescribe and monitor digital health tools for patients from their EHR workflows. These can include patient education, online third-party apps and programs, device monitoring, and non-clinical services such as ride shares, food delivery and e-commerce product recommendations. Using the platform, care teams and physicians can monitor patient engagement and analyze the effects of more engaged patients.
Xealth works with UPMC, the Froedtert and the Medical College of Wisconsin health network, Baylor Scott and White, Duke and other leading health systems.
FinSMEs
28/03/2019